Evidence map›Paper›PMID 16260383›Full record

ReviewNeurotoxicity research2005

The AIDS dementia complex: clinical and basic neuroscience with implications for novel molecular therapies.

B A Navia, K Rostasy

Abstract readReview
PubMed Publisher
In one paragraph

Review in Neurotoxicity research, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Behavioral and molecular evidence for a feedback interaction between morphine and HIV-1 viral proteins.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2012
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. M- and T-tropic HIVs promote apoptosis in rat neurons.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2009
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

B A NaviaDepartment of Community Medicine, Tufts University School of Medicine, Boston MA, USA. Bradford.Navia@Tufts.edu
K Rostasy

Funding

PROTON MRS STUDIES OF CEREBRAL INJURY IN HIV INFECTIONR01NS036524 · NINDS · TUFTS UNIVERSITY BOSTON · PI NAVIA, BRADFORD · 1997 to 2009
$12.9M
Selegiline, Oxidative Stress and MRS in HIV DementiaR01MH064409 · NIMH · UNIVERSITY OF ROCHESTER · PI SCHIFITTO, GIOVANNI · 2001 to 2003
$1.9M
NIMH NIH HHS MH 64409NINDS NIH HHS NS 36524
6 · The paper itself

Abstract

The AIDS dementia complex (ADC, also referred to as HIV-associated cognitive impairment) is a common disorder among HIV-infected patients associated with both inflammatory and neurodegenerative processes. This review describes recent advances in the clinical and basic neurosciences of HIV infection and discusses the multivariable nature of what has become a chronic disorder in the context of highly active antiretroviral therapies (HAART). Since its initial description twenty years ago, advances in cell and molecular biology along with those in neuroimaging have furthered our understanding of the underlying pathogenic mechanisms. The clinical and neuropsychological profile of ADC is generally consistent with a "frontal-subcortical" pattern of injury. Neuropathogenesis is largely driven by indirect mechanisms mediated by infected, or more commonly, immune activated macrophages, which secrete viral and host-derived factors. Magnetic resonance spectroscopy (MRS) provides a robust in vivo method to measure the inflammatory and neurotoxic events triggered by these factors and their associated signals. Although the use of combined or highly active antiretroviral therapies (HAART) has significantly improved survival rates, cerebral injury and cognitive impairment remain common events. Factors such as aging and chronic infection will likely impact the course of this disease, its pathogenesis, and treatment. The combined observations presented in this review suggest a number of critical areas for future inquiry.

Indexed as

AgingAIDS Dementia ComplexAnimalsAntiretroviral Therapy, Highly ActiveBiomarkersBrain ChemistryChemokinesHIV-1HumansNeuronsNeurotoxinsViral LoadBiomarkersChemokinesNeurotoxins

Identifiers

PMID16260383

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.